now playing
Behind the Ozempic Shortage: The Science & Controversy Around Compounded GLP-1’s
Episode 149, duration 1 hr 14 mins
Episode 149
Behind the Ozempic Shortage: The Science & Controversy Around Compounded GLP-1’s
We cover:
- Why compounded GLP-1s are under attack—and what the FDA’s recent moves really means
- How Big Pharma sets drug prices—and why Americans pay up to 10x more than other countries
- The legal battle over semaglutide, regulatory capture, and the influence of pharmaceutical lobbying
- How compounding pharmacies offer personalized care and expand access to life-saving medications
- What’s next for patients, clinicians, and the future of affordable medicine in the U.S.
Who is Shaun Noorian?
Shaun Noorian is the founder and CEO of Empower Pharmacy, the largest compounding pharmacy and 503B outsourcing facility in the United States. A fierce advocate for patient access and affordable care, Shaun has become a leading voice on the role of compounding in medicine and the urgent need for reform in pharmaceutical pricing and regulation.
In this episode, we discuss:
-Why compounded GLP-1s are under attack—and what the FDA’s recent moves really means
– How Big Pharma sets drug prices—and why Americans pay up to 10x more than other countries
– The legal battle over semaglutide, regulatory capture, and the influence of pharmaceutical lobbying
– How compounding pharmacies offer personalized care and expand access to life-saving medications
– What’s next for patients, clinicians, and the future of affordable medicine in the U.S.
Thirty-One to Zero: What the Testosterone Gap Means for Women
For decades, the question about testosterone in women was whether it mattered at all. That question is closed. The real question is why the FDA has approved roughly thirty-one testosterone products for men and exactly zero for women. I put that question to Dr. Susan Read More...
The Pentagon’s Testosterone Memo: What It Says, and Why Military Medicine Is Playing Catch Up
The military community is buzzing right now about a recent Department of War memo and so is much of the medical community. Based on the wildly different interpretations, I wanted to have an open and honest conversation about the memo with someone who had the Read More...
The Variable Almost Nobody Trains: Your Autonomic Nervous System, and Why It May Be Aging You
The world, Kristen Holmes told me, quietly splits into two kinds of people: those who can steer their own autonomic nervous system, and those who get steered by it. The first group does not just carry a competitive edge. In her words, they carry a Read More...














